RenovoRx Income Statement (2024-2025) | RNXT

Income Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.20M0.42M0.27M
Gross Profit 0.10M0.27M0.21M
Operating items
Research & Development 1.64M1.43M1.69M
Selling, General & Administrative 1.57M1.52M1.73M
Operating Expenses 3.21M2.95M3.41M
Operating Income -3.11M-2.68M-3.20M
EBIT -3.11M-2.68M-3.20M
Non-operating items
Interest & Investment Income 0.11M0.13M0.11M
Non Operating Income 0.69M-0.22M0.29M
Net income details
EBT -3.00M-2.54M-3.09M
Profit After Tax -2.42M-2.90M-2.91M
Income from Continuing Operations -3.00M-2.54M-3.09M
Consolidated Net Income -3.00M-2.54M-3.09M
Income towards Parent Company -3.00M-2.54M-3.09M
Net Income towards Common Stockholders -3.00M-2.54M-3.09M
Additional items
EPS (Basic) -0.08-0.08-0.08
EPS (Weighted Average and Diluted) -0.08-0.08-0.08
Shares Outstanding (Weighted Average) 14.95M24.05M24.94M22.27M31.40M36.58M36.65M
Shares Outstanding (Diluted Average) 14.95M24.05M24.94M22.27M31.40M36.58M36.65M
EBITDA -3.11M-2.68M-3.20M
Shares Outstanding 16.87M23.97M24.00M24.03M36.55M36.65M36.65M